This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignees: Novartis Ag, Schering Aktiengesellschaft, Other. Active years: 2002-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bottmingen, CH (2002 - 2006)
- Basel, CH (2022)
Company Filing History:
3 out of 3,978 
2 out of 1,409 
1 out of 834,570 Years Active: 2002-2022
Title: Francesco Hofmann: Innovator in Cancer Treatment
Introduction
Francesco Hofmann is a notable inventor based in Bottmingen, Switzerland. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 4 patents, Hofmann's work focuses on developing personalized therapies and pharmaceutical products aimed at treating neoplastic diseases.
Latest Patents
Hofmann's latest patents include groundbreaking compositions and methods to treat cancer. These innovations provide novel personalized therapies, kits, and methods for treating patients with cancer, particularly those amenable to therapeutic treatment with specific inhibitors. Another significant patent involves N-Aryl (thio) anthranilic acid amide derivatives, which are designed for the treatment of neoplastic diseases that respond to the inhibition of VEGF receptor tyrosine kinase activity. These compounds can be utilized in treating various conditions, including tumor diseases, retinopathy, and age-related macular degeneration.
Career Highlights
Throughout his career, Hofmann has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Schering Aktiengesellschaft. His experience in these organizations has contributed to his expertise in developing innovative treatments for cancer.
Collaborations
Hofmann has collaborated with esteemed colleagues such as Karl-Heinz Altmann and Guido Bold. These partnerships have further enhanced his research and development efforts in the field of cancer therapies.
Conclusion
Francesco Hofmann is a distinguished inventor whose work in cancer treatment has the potential to significantly impact patient care. His innovative patents and collaborations reflect his commitment to advancing medical science and improving therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile